Xilio Development Correlations

XLO Stock

USD 0.63 0.01 1.61%

The current 90-days correlation between Xilio Development and PDS Biotechnology Corp is 0.19 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Xilio Development Correlation With Market

Excellent diversification

The correlation between Xilio Development and DJI is -0.67 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Xilio Stock

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

Moving together with Xilio Stock

0.74	ZLAB	Zai Lab	Pair Corr
0.68	KRRO	Frequency Therapeutics	Pair Corr
0.89	LEGN	Legend Biotech Corp	Pair Corr
0.84	AAPG	Ascentage Pharma Symbol Change	Pair Corr
0.63	SGMO	Sangamo Therapeutics	Pair Corr
0.81	FNMFO	Federal National Mortgage	Pair Corr

Moving against Xilio Stock

0.86	APGE	Apogee Therapeutics	Pair Corr
0.85	GNFT	Genfit SA	Pair Corr
0.82	ANNX	Annexon	Pair Corr
0.8	SRRK	Scholar Rock Holding	Pair Corr
0.79	OABI	OmniAb Inc	Pair Corr
0.78	CELC	Celcuity LLC	Pair Corr
0.75	DSGN	Design Therapeutics	Pair Corr
0.74	ENGN	enGene Holdings Common Trending	Pair Corr
0.69	SLS	Sellas Life Sciences Downward Rally	Pair Corr
0.6	IVVD	Invivyd	Pair Corr
0.57	DMAC	DiaMedica Therapeutics	Pair Corr
0.53	AMGN	Amgen Inc	Pair Corr
0.41	GILD	Gilead Sciences	Pair Corr
0.39	XENE	Xenon Pharmaceuticals	Pair Corr
0.38	CGON	CG Oncology Common	Pair Corr
0.35	AVAL	Grupo Aval	Pair Corr
0.32	OBIO	Orchestra BioMed Holdings	Pair Corr
0.88	JNJ	Johnson Johnson	Pair Corr
0.84	WMT	Walmart Common Stock Sell-off Trend	Pair Corr
0.83	AIZ	Assurant	Pair Corr
0.83	MRK	Merck Company	Pair Corr
0.82	KGC	Kinross Gold Aggressive Push	Pair Corr
0.81	USAS	Americas Silver Corp Trending	Pair Corr
0.79	AA	Alcoa Corp	Pair Corr
0.77	WF	Woori Financial Group	Pair Corr

Related Correlations Analysis

	PDSB	ATNM	TPST	OKUR	LVTX	KZR	FGEN	SKYE	TVRD	ALGS
PDSB		0.06	0.17	0.56	0.04	-0.01	-0.13	0.1	0.41	0.1	PDSB
ATNM	0.06		-0.06	0.09	-0.09	0.53	-0.31	-0.16	0.1	0.63	ATNM
TPST	0.17	-0.06		0.41	-0.47	-0.48	0.83	0.84	0.5	-0.46	TPST
OKUR	0.56	0.09	0.41		-0.15	-0.15	0.12	0.39	0.32	-0.01	OKUR
LVTX	0.04	-0.09	-0.47	-0.15		0.09	-0.37	-0.56	0.02	-0.09	LVTX
KZR	-0.01	0.53	-0.48	-0.15	0.09		-0.51	-0.54	-0.18	0.65	KZR
FGEN	-0.13	-0.31	0.83	0.12	-0.37	-0.51		0.77	0.38	-0.52	FGEN
SKYE	0.1	-0.16	0.84	0.39	-0.56	-0.54	0.77		0.31	-0.35	SKYE
TVRD	0.41	0.1	0.5	0.32	0.02	-0.18	0.38	0.31		0.08	TVRD
ALGS	0.1	0.63	-0.46	-0.01	-0.09	0.65	-0.52	-0.35	0.08		ALGS
	PDSB	ATNM	TPST	OKUR	LVTX	KZR	FGEN	SKYE	TVRD	ALGS

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SKYE	+ 0.84	TPST
FGEN	+ 0.83	TPST
SKYE	+ 0.77	FGEN
ALGS	+ 0.65	KZR
ALGS	+ 0.63	ATNM
OKUR	+ 0.56	PDSB

High negative correlations

SKYE	- 0.56	LVTX
SKYE	- 0.54	KZR
ALGS	- 0.52	FGEN
FGEN	- 0.51	KZR
KZR	- 0.48	TPST
LVTX	- 0.47	TPST

Risk-Adjusted Indicators

There is a big difference between Xilio Stock performing well and Xilio Development Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xilio Development's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PDSB	3.96	(0.07)	0.00	0.04	4.52	(4.76)	8.60	(8.41)	27.78
ATNM	3.33	(0.08)	0.00	(0.08)	0.00	0.00	6.29	(5.33)	25.17
TPST	4.63	(1.52)	0.00	(1.32)	0.00	0.00	7.92	(9.56)	57.69
OKUR	4.07	0.04	0.01	0.10	4.34	(4.46)	9.79	(6.92)	23.27
LVTX	1.33	0.19	0.07	3.63	1.19	(2.29)	4.70	(2.63)	14.75
KZR	0.73	(0.05)	0.00	(0.18)	0.00	0.00	1.46	(1.27)	7.79
FGEN	2.67	(0.09)	0.00	0.12	0.00	0.00	4.33	(5.28)	28.75
SKYE	4.86	(0.36)	0.00	(0.14)	0.00	0.00	10.19	(7.63)	24.11
TVRD	2.78	(0.45)	0.00	(0.76)	0.00	0.00	5.59	(6.23)	15.82
ALGS	4.53	(0.23)	0.00	5.72	0.00	0.00	10.16	(8.73)	28.43

Xilio Development Corporate Management

Martin MD	Pres RD	Profile
Scott Coleman	Chief Officer	Profile
Uli Bialucha	Chief Officer	Profile
Ruth Moulin	Senior Affairs	Profile
Julissa Viana	Vice Communications	Profile
Stacey Davis	Chief Officer	Profile
Christopher Frankenfield	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC